MPTP hydrochloride,23007-85-4,IC-014587

MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxic agent that is a precusor of MPP+ which is toxic to dopaminergic neurons and causes Parkinsonism. It is commonly used in research to induce Parkinson′s disease models in primates. The MPTP neurotoxicity in humans is irreversible and the consequential clinical and neurochemical features closely resemble those of the idiopathic Parkinson’s disease.[1]In vivo analysis demonstrated that systemic MPTP treatments could lead to parkinsonian. Animals developed moderate-to-severe parkinsonian signs, including a marked loss of spontaneous movements (akinesia), muscular rigidity, and severe postural instability.[2] Most of the MPTP and metabolites were excreted in the urine within the first hour after treatment. MPTP metabolite found in the urine during the first hour after treatment is MPTP N-oxide. However, MPTP N-oxide and MPP+ may cause DA depletion only if injected directly into the neostriatum.[1]